Daftar untuk membuat makluman bagi Instrumen,
Acara Ekonomi dan kandungan berdasarkan penulis yang diikuti
Daftar Percuma Sudah mempunyai akaun? Daftar Masuk
Sebutan
Semua Jenis Instrumen
- Semua Jenis Instrumen
- Indeks
- Ekuiti
- ETF
- Dana
- Komoditi
- Matawang
- Kripto
- Bon
- Sijil
Sila cuba carian lain
🤑 Ia sememangnya mampu milik. Rebut POTONGAN 60% tawaran Black Friday ini sebelum ia berlalu…
TUNTUT JUALAN
Rydex Biotechnology Fund Class Investor (RYOIX)
Tambah kepada/Keluarkan daripada Portfolio
Tambah kepada Portfolio
78.88
+0.37
+0.47%
26/11 - Data Tertunda. Matawang dalam USD
- Penarafan Morningstar:
- Jumlah Aset: 81.37M
Rydex Biotechnology Inv
78.88
+0.37
+0.47%
- Tinjauan
- Profil
- Data Sejarah
- Pegangan
Tinjauan RYOIX
Di laman ini anda akan mendapat profil terperinci Rydex Biotechnology Fund Class Investor. Ketahui tentang pengurusan kanan, jumlah aset, strategi pelaburan dan maklumat untuk dihubungi RYOIX antara maklumat lain.
Maklumat Untuk Dihubungi
Alamat
9601 Blackwell Rd, Suite 500
Rockville,MD 20850
United States
Rockville,MD 20850
United States
Telefon
800.820.0888
Eksekutif Tinggi
| Nama | Tajuk | Sejak | Sehingga |
|---|---|---|---|
| Adrian Bachman | Portfolio Manager | 2022 | now |
| Biografi | Mr. Bachman is a Director and Portfolio Manager of Guggenheim Investments and joined Guggenheim Investments in August of 2014. Before joining Guggenheim Investments, Mr. Bachman spent six years at Arrow Investment Advisors. As portfolio manager, Mr. Bachman managed the Arrow Dow Jones Global Yield ETF (GYLD) which provided multi asset class diversified income across five unique sources including high dividend paying global equities, real estate investment trusts, MLPs, sovereign debt and high yield corporate bonds. While at Arrow he also aided in the management of numerous other funds. Before joining Arrow Funds in June of 2008, Mr. Bachman spent eleven years at Rydex Investments in Rockville, Maryland. As portfolio manager, Mr. Bachman managed Rydex's Sector Rotation Fund and several sector funds. During the course of his tenure with Rydex, he also aided in the management of numerous other funds including Rydex's inverse, leveraged and international funds. Mr. Bachman has a bachelor's degree in finance and international business from the University of Maryland, College Park and has earned the Chartered Financial Analyst designation. | ||
| Brendan Cain | Portfolio Manager | 2022 | now |
| Biografi | Brendan Cain, CFA, Vice President and Portfolio Manager. Mr. Cain has been associated with the Adviser since 2006. | ||
| Spencer Crane | Portfolio Manager | 2022 | now |
| Biografi | Spencer Crane, CFA, Vice President and Portfolio Manager. Mr. Crane has been associated with the Adviser since 2012 | ||
| Scott Miller | Portfolio Manager | 2022 | now |
| Biografi | Scott Miller, Vice President and Portfolio Manager. Mr. Miller has been associated with the Adviser since 2008. | ||
| Michael P. Byrum | Vice President | 1998 | now |
| Biografi | Michael P. Byrum, CFA, Senior Vice President—Mr. Byrum has been associated with the Security Investors since 1993. Mr. Byrum was the inaugural portfolio manager for many of the Rydex products, including the Rydex leveraged and inverse funds, sector fund lineup and alternative investment portfolios. Today, Mr. Byrum continues to play an instrumental role in product development and investment strategy at Guggenheim Investments and oversees the trading, research and portfolio management activities of the quantitative strategies team, which focuses on target beta, alternative and asset allocation strategies. He is the chairman of the Investment Strategy Committee and is a member of the Risk Management Committee and Credit Review Committee. Prior to joining the Security Investors， Mr. Byrum served in a brokerage capacity with Money Management Associates, the registered investment advisor to Rushmore Funds, Inc. He earned a B.S. in finance from the Miami University of Ohio. He also has earned the right to use the Chartered Financial Analyst® designation and is a member of the CFA Institute and the CFA Society of Washington. | ||
| Ryan A. Harder | Graduate Trainee Risk Management | 2008 | 2022 |
| Biografi | Ryan earned a BA in Economics, with honors, from Brock University in Ontario, Canada, and a M.Sc. in International Securities, Investment and Banking form the ICMA Centre, University of Reading, in the United Kingdom. He is a CFA Charterholder. | ||
| Michael J. Dellapa | Director | 2006 | 2015 |
| Biografi | Dellapa joined Rydex Investments in 2000 as a research analyst and was promoted to portfolio manager in 2003. In 2005, Dellapa became director of investment research and in 2007 became the director of Alternative Investment Strategies. Prior to joining Rydex Advisors, LLC, Mr. Dellapa worked as an equity analyst for Invista Capital and systems analyst for Accenture. He holds an engineering degree from the University of Maryland and MBA from the University of Chicago. Previously, he was owner/consultant of Dellapa Consulting Inc. as well as a senior consultant and an analyst at Andersen Consulting. Dellapa holds the Charted Financial Analyst designation. | ||
| Douglas T. Holmes | Strategic Advisor | 2008 | 2009 |
| Biografi | Doug is a Senior Principal of State Street Global Advisors and heads the Global Enhanced Equity Group. He specializes in portfolio construction, risk control, and implementation of enhanced equity portfolios. Doug is the co-inventor of SPDRs and continues to be involved in all related products discussed or created by the firm. Prior to joining State Street in 1984, Doug was a partner at Lovett, Ward & Bertelsen. Before this, he was affiliated with Batterymarch Financial Management and was a member of the New Product Committee of the American Stock Exchange. Doug has been working in the investment management industry since 1980. Doug has a BS in Mathematics from Northeastern University. | ||
| James R. King | Director | 2006 | 2008 |
| Biografi | James R. King, CFA, Portfolio Manager—Mr. King rejoined Security in 2011 as the lead portfolio manager for exchange-traded products. In the interval between 2008 and 2011, he served as special consultant to a pair of hedge funds ventures, one focused on long-short equity and the other on market neutral statistical arbitrage. Prior to that, he served at the Advisor in a variety of roles ranging from shareholder services representative to portfolio manager and director of trading. At the time of his departure in 2008, he was director of portfolio management, overseeing a suite of trader-friendly mutual funds. Mr. King holds a bachelor’s degree in finance from the University of Maryland, and has earned the Chartered Financial Analyst® designation. He has been quoted in several publications such as The Wall Street Journal, Reuters and BusinessWeek. He has also been a speaker at several industry events, discussing ETFs, trading strategies, index construction, and trader-friendly mutual funds. | ||
Tulis pendapat anda tentang Rydex Biotechnology Fund Class Investor
Adakah anda pasti anda mahu padamkan carta ini?
Padam Batal
Gantikan carta yang disertakan dengan carta baru?
Ganti Batal
Garis Panduan Komen
Tambah Carta kepada Komen
Sahkan Halangan
Adakah anda pasti anda mahu halang %USER_NAME%?
Dengan berbuat demikian, anda dan %USER_NAME% tidak akan dapat melihat post satu sama lain.
%USER_NAME% telah berjaya ditambah ke Senarai Halangan anda
Oleh kerana anda baru sahaja berhenti halang orang ini, anda perlu menunggu 48 jam sebelum memperbaharui halangan itu.
Laporkan komen ini
Saya berpendapat komen ini:
Komen ditandakan
Thank You!
Laporan anda telah dihantar kepada moderator untuk semakan